Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Talia Shentzer-Kutiel"'
Autor:
Ofri Doppelt-Flikshtain, Amin Younis, Tal Tamari, Ofir Ginesin, Talia Shentzer-Kutiel, David Nikomarov, Gil Bar-Sela, Benjamin R. Coyac, Yehuda G. Assaraf, Hadar Zigdon-Giladi
Publikováno v:
Cancers; Volume 15; Issue 6; Pages: 1818
Background: Osteosarcoma (OS) mortality is attributed to lung metastases. Endothelial progenitor cells (EPCs) mediate the angiogenic switch in several cancers. The spatial proximity between EPCs and OS in the bone led to the hypothesis that EPCs-oste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d43f028844ce7a56730ba9c1895a0eb6
Publikováno v:
Pharmaceuticals, Vol 13, Iss 6, p 129 (2020)
Adjuvant chemotherapy is recommended in high-risk stage II–III colorectal cancer (CC). We examine the effect of daily wheatgrass juice (WGJ) intake in addition to chemotherapy on immune parameters, including IL-6, IL-8, IL-10, IL-12, and white bloo
Externí odkaz:
https://doaj.org/article/7b31fc3064ed48349ebc732e73e1c75f
Publikováno v:
Pharmaceuticals
Volume 13
Issue 6
Pharmaceuticals, Vol 13, Iss 129, p 129 (2020)
Volume 13
Issue 6
Pharmaceuticals, Vol 13, Iss 129, p 129 (2020)
Adjuvant chemotherapy is recommended in high-risk stage II&ndash
III colorectal cancer (CC). We examine the effect of daily wheatgrass juice (WGJ) intake in addition to chemotherapy on immune parameters, including IL-6, IL-8, IL-10, IL-12, and w
III colorectal cancer (CC). We examine the effect of daily wheatgrass juice (WGJ) intake in addition to chemotherapy on immune parameters, including IL-6, IL-8, IL-10, IL-12, and w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::401adfc4623a98f0264afd0cebb495de
https://pubmed.ncbi.nlm.nih.gov/32585974
https://pubmed.ncbi.nlm.nih.gov/32585974
Autor:
Talia Golan, Talia Shentzer Kutiel, Maya Gottfried, Alona Zer, Aviad Zick, Ayelet Shai, Larissa Ryvo, Julia Dudnik, Nir Peled, Galia Oberkovitz, Fan Yang, Shmuel Sharoni, Changting Meng, Dayana Michel, Eric Sbar, Jatin J. Shah, Michael Kauffman, Sharon Shacham, Ravit Geva
Publikováno v:
Journal of Clinical Oncology. 40:110-110
110 Background: Single agent selinexor, an oral selective inhibitor of nuclear export (SINE), showed activity against heavily pretreated CRC with RAS mutations (mut) or wildtype (wt) in 2 clinical studies. In preclinical studies, selinexor showed sup
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d402b6e574cc99a54be05b5ec247048b
https://doi.org/10.1200/jco.2022.40.4_suppl.110
https://doi.org/10.1200/jco.2022.40.4_suppl.110
Autor:
Alona Zer, Maya Gottfried, Michael Kauffman, Jatin J. Shah, Fan Yang, Einat Netiv, Julia Dudnik, Sharon Shacham, Ravit Geva, J. Paul Duic, Changting Meng, Yue Zhang, Talia Golan, Shmuel Sharoni, Talia Shentzer Kutiel, Dayana Michel, Aviad Zick
Publikováno v:
Journal of Clinical Oncology. 39:e15579-e15579
e15579 Background: Colorectal cancer (CRC) is the fourth leading cause of cancer-related deaths worldwide and is heterogenous in its molecular features. Checkpoint inhibitors (CPIs) are approved for only about 5% of unresectable or metastatic CRC wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a73f931605cf172efad9361be275aecd
https://doi.org/10.1200/jco.2021.39.15_suppl.e15579
https://doi.org/10.1200/jco.2021.39.15_suppl.e15579
Publikováno v:
Journal of Pain and Symptom Management. 55:e1-e2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57a71a2a39e7ad9d22e966852f7e48cb
https://doi.org/10.1016/j.jpainsymman.2018.02.004
https://doi.org/10.1016/j.jpainsymman.2018.02.004
Publikováno v:
Journal of Clinical Oncology. 37:e23045-e23045
e23045 Background: Adjuvant chemotherapy is recommended in stage II-III colorectal cancer (CC). Wheatgrass juice (WGJ), has high nutritional values may attenuate chemotherapy adverse events (AE). Extracellular vehicles (EVs) are subcellular membrane
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42fb6b39cde0ee123c9d61885c7b8278
https://doi.org/10.1200/jco.2019.37.15_suppl.e23045
https://doi.org/10.1200/jco.2019.37.15_suppl.e23045